Hellen Ishikawa‐Ankerhold

2.6k total citations
50 papers, 1.1k citations indexed

About

Hellen Ishikawa‐Ankerhold is a scholar working on Immunology, Molecular Biology and Cell Biology. According to data from OpenAlex, Hellen Ishikawa‐Ankerhold has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 15 papers in Molecular Biology and 11 papers in Cell Biology. Recurrent topics in Hellen Ishikawa‐Ankerhold's work include Cellular Mechanics and Interactions (9 papers), Advanced Fluorescence Microscopy Techniques (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Hellen Ishikawa‐Ankerhold is often cited by papers focused on Cellular Mechanics and Interactions (9 papers), Advanced Fluorescence Microscopy Techniques (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Hellen Ishikawa‐Ankerhold collaborates with scholars based in Germany, Slovakia and United States. Hellen Ishikawa‐Ankerhold's co-authors include Gregor P. C. Drummen, Richard Ankerhold, Annette Müller‐Taubenberger, Günther Gerisch, Mary Ecke, Till Bretschneider, Kurt I. Anderson, Britta Schroth‐Diez, Christian Schulz and Rainer Haas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hellen Ishikawa‐Ankerhold

47 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hellen Ishikawa‐Ankerhold

Since Specialization

Citations

This map shows the geographic impact of Hellen Ishikawa‐Ankerhold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hellen Ishikawa‐Ankerhold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hellen Ishikawa‐Ankerhold more than expected).

Fields of papers citing papers by Hellen Ishikawa‐Ankerhold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hellen Ishikawa‐Ankerhold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hellen Ishikawa‐Ankerhold. The network helps show where Hellen Ishikawa‐Ankerhold may publish in the future.

Co-authorship network of co-authors of Hellen Ishikawa‐Ankerhold

This figure shows the co-authorship network connecting the top 25 collaborators of Hellen Ishikawa‐Ankerhold. A scholar is included among the top collaborators of Hellen Ishikawa‐Ankerhold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hellen Ishikawa‐Ankerhold. Hellen Ishikawa‐Ankerhold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Homeostasis of megakaryocytes: balancing tissue residency and consumptive platelet production 2025 ·Trends in Cell Biology ·Wenwen Fu, Hellen Ishikawa‐Ankerhold, Florian Gaertner	0
2	A distinct population of CD8+ T cells expressing CD39 and CD73 accumulates with age and supports cancer progression 2025 ·Nature Aging ·Monica Bodogai, Bong Soo Park, (unknown), (unknown), (unknown), Chen Chen, Emeline Ragonnaud, (unknown), Steffen Ormanns, (unknown), Hellen Ishikawa‐Ankerhold, Supriyo De, Luigi Ferrucci, Ranjan Sen, Zhana Duren, Isabel Beerman, Arya Biragyn	1
3	PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis 2024 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), (unknown), (unknown), Tao Xu, Alexander Beck, (unknown), Katharina Müller, Nico Teske, Philipp Karschnia, (unknown), (unknown), Hellen Ishikawa‐Ankerhold, Niklas Thon, Joerg‐Christian Tonn, Marion Subklewe, Sebastian Kobold, Patrick N. Harter, Veit R. Buchholz, Louisa von Baumgarten	1
4	CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis 2024 ·Brain Behavior and Immunity ·Xin Wang, (unknown), Monica Bodogai, Ross A. McDevitt, (unknown), Fedor Gusev, Emeline Ragonnaud, (unknown), (unknown), (unknown), (unknown), Drew Weissman, Hellen Ishikawa‐Ankerhold, Eitan Okun, Е. И. Рогаев, Arya Biragyn	9
5	Novel multiphoton intravital imaging enables real-time study of Helicobacter pylori interaction with neutrophils and macrophages in the mouse stomach 2024 ·PLoS Pathogens ·Hellen Ishikawa‐Ankerhold, Benjamin Busch, (unknown), Daniela Begandt, (unknown), Sukumar Namineni, Mykhailo Vladymyrov, Ute Harrison, (unknown), Lukas Tomas, Barbara Walzog, Steffen Maßberg, Christian Schulz, Rainer Haas	0
6	Helicobacter pylori binds human Annexins via Lipopolysaccharide to interfere with Toll-like Receptor 4 signaling 2022 ·PLoS Pathogens ·(unknown), (unknown), (unknown), Hong Li, Sukumar Namineni, Hellen Ishikawa‐Ankerhold, Luisa F. Jiménez‐Soto, Rainer Haas	20
7	Type I interferon mediated induction of somatostatin leads to suppression of ghrelin and appetite thereby promoting viral immunity in mice 2021 ·Brain Behavior and Immunity ·Susanne Stutte, (unknown), (unknown), Hellen Ishikawa‐Ankerhold, (unknown), Peggy Marconi, Takahiro Maeda, Tsuneyasu Kaisho, Anne Krug, Bastian Popper, Henning Lauterbach, Marco Colonna, Ulrich H. von Andrian, Thomas Brocker	8
8	Modulation of the Host Nuclear Compartment by Trypanosoma cruzi Uncovers Effects on Host Transcription and Splicing Machinery 2021 ·Frontiers in Cellular and Infection Microbiology ·(unknown), (unknown), (unknown), (unknown), Marcelo D. Gomes, Hellen Ishikawa‐Ankerhold, Munira Muhammad Abdel Baqui	5
9	Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage 2021 ·International Journal of Molecular Sciences ·(unknown), Anca Chelariu-Raicu, Ye Yao, Zhi Ma, (unknown), Hellen Ishikawa‐Ankerhold, Martina Rahmeh, Sven Mahner, Udo Jeschke, Viktoria von Schönfeldt	8
10	Multiphoton Intravital Imaging for Monitoring Leukocyte Recruitment during Arteriogenesis in a Murine Hindlimb Model 2021 ·Journal of Visualized Experiments ·(unknown), Mykhailo Vladymyrov, (unknown), (unknown), Elisabeth Deindl, Hellen Ishikawa‐Ankerhold	1
11	Single platelet and megakaryocyte morpho-dynamics uncovered by multicolor reporter mouse strains <i>in vitro</i> and <i>in vivo</i> 2021 ·Haematologica ·Leo Nicolai, Rainer Kaiser, Raphael Escaig, Marie‐Louise Hoffknecht, Afra Anjum, Alexander Leunig, Joachim Pircher, Andreas Ehrlich, Michael Lorenz, Hellen Ishikawa‐Ankerhold, William C. Aird, Steffen Maßberg, Florian Gaertner	6
12	In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer 2021 ·Neoplasia ·Wenlong Zhang, Philipp Karschnia, (unknown), Matthias Mulazzani, (unknown), (unknown), (unknown), Nico Teske, (unknown), Tao Xu, Niklas Thon, Hellen Ishikawa‐Ankerhold, Andreas Straube, Joerg‐Christian Tonn, Louisa von Baumgarten	13
13	The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma 2020 ·Frontiers in Oncology ·(unknown), Matthias Mulazzani, (unknown), (unknown), Wenlong Zhang, Hellen Ishikawa‐Ankerhold, Martin Dreyling, Andreas Straube, Louisa von Baumgarten	9
14	Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice 2019 ·Proceedings of the National Academy of Sciences ·Matthias Mulazzani, Simon P. Fräßle, (unknown), (unknown), (unknown), Hellen Ishikawa‐Ankerhold, Justin Leube, (unknown), (unknown), (unknown), Martina Rudelius, Martin Dreyling, Michael von Bergwelt‐Baildon, Andreas Straube, Veit R. Buchholz, Dirk H. Busch, Louisa von Baumgarten	73
15	Anti α-enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages 2019 ·EBioMedicine ·Ye Yao, Christina Kühn, (unknown), Georg J. Arnold, Hellen Ishikawa‐Ankerhold, Christian Schulz, Nina Rogenhofer, Christian J. Thaler, Sven Mahner, Thomas Fröhlich, Udo Jeschke, Viktoria von Schönfeldt	15
16	Actin assembly states in Dictyostelium discoideum at different stages of development and during cellular stress 2019 ·The International Journal of Developmental Biology ·Hellen Ishikawa‐Ankerhold, Annette Müller‐Taubenberger	6
17	Integrin but not CEACAM receptors are dispensable for Helicobacter pylori CagA translocation 2018 ·PLoS Pathogens ·(unknown), Benjamin Busch, Luisa F. Jiménez‐Soto, Hellen Ishikawa‐Ankerhold, (unknown), Laurent Terradot, Wolfgang Fischer, Rainer Haas	43
18	Fluorescent Reporters and Methods to Analyze Fluorescent Signals 2013 ·Methods in molecular biology ·Annette Müller‐Taubenberger, Hellen Ishikawa‐Ankerhold	29
19	Overexpression of myosin-IIB in the brain of a rat model of streptozotocin-induced diabetes 2011 ·Journal of the Neurological Sciences ·(unknown), (unknown), Rafael Nascimento, (unknown), (unknown), (unknown), (unknown), Hellen Ishikawa‐Ankerhold, Marcelo Valle de Sousa, Luíz Ricardo Goulart, Foued Salmen Espíndola	8
20	The Three-Dimensional Dynamics of Actin Waves, a Model of Cytoskeletal Self-Organization 2009 ·Biophysical Journal ·Till Bretschneider, Kurt I. Anderson, Mary Ecke, Annette Müller‐Taubenberger, Britta Schroth‐Diez, Hellen Ishikawa‐Ankerhold, Günther Gerisch	156

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact